Trinova-3/Engot-Ov-2/Gog-3001: A Randomized, Double-Blind Phase 3 Study Of Trebananib Plus Carboplatin/Paclitaxel As First-Line Treatment In Advanced Ovarian Cancer

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER(2016)

引用 3|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要